LeLeu X - Search Results

1

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Fernández de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH, Hajek R, San Miguel JF, Sezer O, Sonneveld P, Kumar SK, Mahindra A, Comenzo R, Palumbo A, Mazumber A, Anderson KC, Richardson PG, Badros AZ, Caers J, Cavo M, LeLeu X, Dimopoulos MA, Chim CS, Schots R, Noeul A, Fantl D, Mellqvist UH, Landgren O, Chanan-Khan A, Moreau P, Fonseca R, Merlini G, Lahuerta JJ, Bladé J, Orlowski RZ, Shah JJ; International Myeloma Working Group. Fernández de Larrea C, et al. Among authors: leleu x. Leukemia. 2013 Apr;27(4):780-91. doi: 10.1038/leu.2012.336. Epub 2012 Nov 21. Leukemia. 2013. PMID: 23288300 Free PMC article. Review.

2

Isolated neurological relapse following stem cell transplantation in plasma cell leukemia: a report of two cases.

Leleu X, Jouet JP, Plantier I, Zandecki M, Laï JL, Mucha D, Lejeune JP, Bauters F, Facon T. Leleu X, et al. Leukemia. 1999 Feb;13(2):307-9. doi: 10.1038/sj.leu.2401309. Leukemia. 1999. PMID: 10025908 No abstract available.

3

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy.

Facon T, Avet-Loiseau H, Guillerm G, Moreau P, Geneviève F, Zandecki M, Laï JL, Leleu X, Jouet JP, Bauters F, Harousseau JL, Bataille R, Mary JY; Intergroupe Francophone du Myélome. Facon T, et al. Among authors: leleu x. Blood. 2001 Mar 15;97(6):1566-71. doi: 10.1182/blood.v97.6.1566. Blood. 2001. PMID: 11238092 Free article.

4

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.

Moreau P, Facon T, Leleu X, Morineau N, Huyghe P, Harousseau JL, Bataille R, Avet-Loiseau H; Intergroupe Francophone du Myélome. Moreau P, et al. Among authors: leleu x. Blood. 2002 Sep 1;100(5):1579-83. doi: 10.1182/blood-2002-03-0749. Blood. 2002. PMID: 12176874 Free article.

5

Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor.

Vande Broek I, Asosingh K, Allegaert V, Leleu X, Facon T, Vanderkerken K, Van Camp B, Van Riet I. Vande Broek I, et al. Among authors: leleu x. Leukemia. 2004 May;18(5):976-82. doi: 10.1038/sj.leu.2403331. Leukemia. 2004. PMID: 14999296

6

Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma.

Depil S, Leleu X, Micol JB, Berthon C, Laï JL, Bauters F, Quesnel B, Facon T. Depil S, et al. Among authors: leleu x. Leuk Lymphoma. 2004 Dec;45(12):2481-4. doi: 10.1080/10428190412331283224. Leuk Lymphoma. 2004. PMID: 15621764

7

Irregular nuclear shape of bone marrow plasma cells defines a multiple myeloma subgroup related to hypodiploidy and to short survival.

Leleu X, Genevieve F, Guieze R, Duhamel A, Andrieux J, Berthon C, Godon A, Prat-Lesaffre S, Depil S, Lai JL, Facon T, Zandecki M; Intergroupe Francophone du Myelome (IFM). Leleu X, et al. Leuk Res. 2005 Jun;29(6):665-71. doi: 10.1016/j.leukres.2004.12.002. Epub 2005 Mar 28. Leuk Res. 2005. PMID: 15863207

8

Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.

Vande Broek I, Leleu X, Schots R, Facon T, Vanderkerken K, Van Camp B, Van Riet I. Vande Broek I, et al. Among authors: leleu x. Haematologica. 2006 Feb;91(2):200-6. Haematologica. 2006. PMID: 16461304

9

[Prognostic factors and new treatments of multiple myeloma].

Leleu X, Coiteux V, Facon T. Leleu X, et al. Rev Prat. 2006 Jan 15;56(1):31-9. Rev Prat. 2006. PMID: 16548247 Review. French.

10

Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.

Harousseau JL, Attal M, Leleu X, Troncy J, Pegourie B, Stoppa AM, Hulin C, Benboubker L, Fuzibet JG, Renaud M, Moreau P, Avet-Loiseau H. Harousseau JL, et al. Among authors: leleu x. Haematologica. 2006 Nov;91(11):1498-505. Epub 2006 Oct 17. Haematologica. 2006. PMID: 17043025 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page